Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear.

The interview with Dr Asad Khan on long Covid (Solidarity 747-748) highlights the contribution to the growth in mental ill-health of widespread long Covid, which affects hundreds of millions of ...

Research shows that COVID tends to spike twice annually — once in the winter and once in the summer, and, like past years, ...

Black and Latino patients were less likely to be prescribed oral antivirals for COVID-19 compared with white patients. Barriers such as limited access to clinicians and home tests may drive a ...

Two new COVID-19 variants are spreading across the country and doctors in Connecticut are expecting they could bring an uptick in cases.

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

The HK gov't has announced that it will stop sponsoring private doctors to provide free Covid-19 oral antiviral pills from ...

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...

It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...

COVID-19 cases are rising in more than half of states. Is the US in a summer wave? What to know about COVID trends and ...

Up to 60 percent of older adults live with persistent muscle pain, but there’s a lot you can do to ease that discomfort.